Rekha Raghunathan — Eli Lilly (United States)

Area of research

Cardiology and Cardiovascular Medicine · Molecular Biology

Research interest

Research interests include Cardiac Fibrosis and Remodeling, Glycosylation and Glycoproteins Research, Parkinson's Disease Mechanisms and Treatments, and Advanced Proteomics Techniques and Applications.

Recent publications

Matrisome changes in Parkinson’s disease

Analytical and Bioanalytical Chemistry 2022cited by 31position: middledoi

Expression of the Extracellular Sulfatase SULF2 Affects Survival of Head and Neck Squamous Cell Carcinoma Patients

Frontiers in Oncology 2021cited by 23position: middledoi

A glycomics and proteomics study of aging and Parkinson’s disease in human brain

Scientific Reports 2020cited by 63position: firstdoi

Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules

Molecular & Cellular Proteomics 2019cited by 53position: firstdoi

On-slide tissue digestion for mass spectrometry based glycomic and proteomic profiling

MethodsX 2019cited by 36position: firstdoi

Emerging Biomarkers in Cutaneous Melanoma

Molecular Diagnosis & Therapy 2018cited by 51position: middledoi

Glycomic and Proteomic Changes in Aging Brain Nigrostriatal Pathway

Molecular & Cellular Proteomics 2018cited by 40position: firstdoi

Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells

Molecular Cancer Research 2015cited by 67position: middledoi

Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma

Journal of Investigative Dermatology 2015cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cardiology and Cardiovascular Medicine · Molecular Biology →